Status and phase
Conditions
Treatments
About
The purpose of this study is to determine the accuracy of the Novel point of care test (POCT) total IgE assay in atopic patients.
120 patients with atopic conditions and approximately 40 healthy subjects will be enrolled. Fingerstick capillary blood samples will be collected and tested in the POCT device. Venous samples will be collected and sent to a reference laboratory for measurement of serum total IgE using the reference immunoassay method.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion criteria: atopic patients
Exclusion criteria: healthy subjects
Primary purpose
Allocation
Interventional model
Masking
193 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal